← Back to Screener
GRAIL, Inc. Common Stock (GRAL)
Price$49.47
Favorite Metrics
Price vs S&P 500 (26W)-35.58%
Price vs S&P 500 (4W)-2.97%
Market Capitalization$2.04B
All Metrics
Book Value / Share (Quarterly)$63.92
P/TBV (Annual)4.59x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)38.37%
Cash Flow / Share (Quarterly)$-7.44
Price vs S&P 500 (YTD)-44.47%
Gross Margin (TTM)48.46%
Net Profit Margin (TTM)-277.47%
EPS (TTM)$-11.18
10-Day Avg Trading Volume0.95M
EPS Excl Extra (TTM)$-11.18
EPS (Annual)$-11.11
ROI (Annual)-15.84%
Gross Margin (Annual)48.46%
Net Profit Margin (5Y Avg)-4344.87%
Cash / Share (Quarterly)$22.43
Revenue Growth QoQ (YoY)13.97%
ROA (Last FY)-13.97%
Revenue Growth TTM (YoY)17.18%
EBITD / Share (TTM)$-11.68
ROE (5Y Avg)-53.29%
Operating Margin (TTM)-381.98%
Cash Flow / Share (Annual)$-7.44
P/B Ratio0.79x
P/B Ratio (Quarterly)1.29x
Net Income / Employee (Annual)$-0
EV / Revenue (TTM)12.18x
ROA (TTM)-14.75%
EPS Incl Extra (Annual)$-11.11
Current Ratio (Annual)11.97x
Quick Ratio (Quarterly)11.78x
3-Month Avg Trading Volume1.15M
52-Week Price Return100.36%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$18.03
P/S Ratio (Annual)13.88x
Asset Turnover (Annual)0.05x
52-Week High$118.84
Operating Margin (5Y Avg)-4442.08%
EPS Excl Extra (Annual)$-11.11
CapEx CAGR (5Y)-22.88%
26-Week Price Return-31.60%
Quick Ratio (Annual)11.78x
13-Week Price Return-53.00%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)11.97x
Enterprise Value$1,792.671
Asset Turnover (TTM)0.05x
Revenue / Employee (Annual)$0
Pretax Margin (Annual)-363.18%
Cash / Share (Annual)$22.43
3-Month Return Std Dev134.11%
Gross Margin (5Y Avg)37.30%
Net Income / Employee (TTM)$-0
ROE (Last FY)-15.84%
EPS Basic Excl Extra (Annual)$-11.11
Receivables Turnover (TTM)7.62x
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-11.18
Receivables Turnover (Annual)7.62x
ROI (TTM)-17.11%
P/S Ratio (TTM)13.88x
Pretax Margin (5Y Avg)-4431.73%
Revenue / Share (Annual)$4.00
Tangible BV / Share (Annual)$18.03
Price vs S&P 500 (52W)70.53%
Year-to-Date Return-41.83%
5-Day Price Return4.69%
EPS Normalized (Annual)$-11.11
ROA (5Y Avg)-48.30%
Net Profit Margin (Annual)-277.47%
Month-to-Date Return-3.66%
EBITD / Share (Annual)$-11.68
Operating Margin (Annual)-381.98%
ROI (5Y Avg)-53.29%
EPS Basic Excl Extra (TTM)$-11.18
P/TBV (Quarterly)4.59x
P/B Ratio (Annual)1.29x
Pretax Margin (TTM)-363.18%
Book Value / Share (Annual)$63.92
Price vs S&P 500 (13W)-53.68%
Beta1.93x
Revenue / Share (TTM)$3.61
ROE (TTM)-17.11%
52-Week Low$23.80
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.00
4.00
4.00
4.08
Industry Peers — Health Services(20)
| Symbol | P/E Ratio (Annual) | Revenue Growth TTM (YoY) | Operating Margin (TTM) | ROE (TTM) | Price |
|---|---|---|---|---|---|
GRALGRAIL, Inc. Common Stock | — | 17.18% | -381.98% | -17.11% | $49.47 |
NTRANatera, Inc. Common Stock | — | 35.90% | -13.44% | -15.28% | $196.11 |
LHLabcorp Holdings Inc. | 25.08x | 7.25% | 9.92% | 10.28% | $266.36 |
DGXQuest Diagnostics Inc. | 21.24x | 11.78% | 14.10% | 13.88% | $191.46 |
EXASExact Sciences Corp | — | 17.69% | -6.35% | -8.51% | $104.91 |
GHGuardant Health, Inc. Common Stock | — | 32.88% | -45.02% | -246.60% | $85.70 |
RDNTRadNet, Inc. Common Stock | 1779.27x | 11.51% | 3.04% | -1.88% | $60.09 |
VCYTVeracyte, Inc. | 40.04x | 16.01% | 11.17% | 5.33% | $33.03 |
CDNACareDx, Inc. | 18.34x | 13.79% | -8.10% | -6.47% | $22.42 |
FTREFortrea Holdings Inc. Common Stock | — | 1.00% | -32.04% | -152.17% | $10.09 |
CSTLCastle Biosciences, Inc. Common Stock | 47.31x | 3.66% | -12.44% | -5.27% | $24.56 |
About
GRAIL Inc develops a blood-based test for multi-cancer early detection designed to identify various cancer types at earlier stages. The company provides testing services focused on enabling earlier diagnosis and intervention, operating as a single business segment dedicated to cancer detection technology.